Today's top medical abstracts
Rheumatology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?

Home
General Rheumatology
For Practicing
Rheumatologists
Conferences
Jobs
Newsletters
My Library
Topics in
Rheumatology
        Amyloidosis
        Autoimmune/Heritable
        Basic Science/Genetics
        Bone Metabolism
        Chr Fatigue/Fibromyalgia
        Clinical Pharmacology
        Connective Tissue Dz
        Diagnostics/Radiology
        Economics of Medicine
        Gout and Hyperuricemia
        Infectious Arthritis
        Osteoarthritis
        Other Arthritis
        Pediatric Rheumatology
        Popular Press
        Rheumatoid Arthritis
        Spondylarthropathies
        Systemic Lupus (SLE)
        Vasculitic Syndromes
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor
For Practicing Rheumatologists
Today's Rheumatology News: VGX-1027 To Undergo Additional Testing For RA
D Scott Cunningham MD, PhD, MDLinx Rheumatology
Today's Rheumatology News: FDA Approves Actemra
D Scott Cunningham MD, PhD, MDLinx Rheumatology
From the Editors: New Clinical-Only Option for MDLinx!
Stephen Smith, MDLinx
  See all
fibromyalgia;circulating cytoline levels compared to pain Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website
Circulating cytokine levels compared to pain in patients with fibromyalgia - a prospective longitudinal study over 6 months
Journal of Rheumatology, 06/04/08
Print     Email This Article     Save in My Library   Free Abstract
Wang H et al. – This data suggest that the proinflammatory cytokines TNF-α and IL-8 are involved in fibromyalgia (FM), but they do not apparently provoke the pain of FM directly. Multidisciplinary pain therapy modified the cytokine profile in patients with FM during the observation period.

Methods
  • Study to examine the circulating cytokines in FM pts over a period of 6 mos and to find the correlations between serum cytokine concs and pain intensity in pts receiving multidisciplinary pain therapy
  • Serum concs of IL-6, IL-8, TNF-α and IL-4 and IL-10 were measured in 20 FM pts and 80 healthy subjects on admission and 10, 21, and 180 days after initiation of treatment

Results
  • On admission, serum levels of IL-8 and TNF-α but not IL-6, were elevated in FM pts
  • No difference in IL-4 and IL-10 was found between FM pts and controls
  • High IL-8 levels remained consistent during the f/u, but TNF-&apha; was already reduced after 10 days and until 6 mos after therapy
  • After 6 mos' treatment with multidisciplinary pain therapy, IL-8 and TNF-α levels were lower than at the beginning
  • IL-8 but not TNF-α serum levels were correlated with pain intensity in FM pts after 6 mos' multidisciplinary pain therapy

Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.